GoodRx Holdings (GDRX) Total Current Liabilities (2019 - 2026)

GoodRx Holdings' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $859.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 731.08% year-over-year to $859.2 million; the TTM figure through Mar 2026 stood at $859.2 million (up 731.08% YoY), while the FY2025 annual figure was $246.0 million, up 98.54% from the prior year.
• Total Current Liabilities came in at $859.2 million for Q1 2026 at GoodRx Holdings, up from $246.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $859.2 million in Q1 2026 to a low of $59.4 million in Q1 2022.
• A 5-year average of $157.1 million and a median of $114.4 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities decreased 11.28% in 2025 and jumped 731.08% in 2026, its largest moves.
• GoodRx Holdings' Total Current Liabilities stood at $76.3 million in 2022, then surged by 60.59% to $122.6 million in 2023, then increased by 1.1% to $123.9 million in 2024, then jumped by 98.54% to $246.0 million in 2025, then jumped by 249.26% to $859.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $859.2 million, $246.0 million, and $181.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison